Peripheral blood leucocytes ornithine decarboxylase activity in chronic myeloid leukemia patients: Prognostic and therapeutic implications

Leukemia Research

Volumn 26, Issue 4, 2002, Pages 349-354

  Tripathi, Anil K ^a,d   Chaturvedi, Rupesh ^a   Ahmad, Rizwan ^a   Asim, Mohd ^a   Sawlani, Kamal K ^a   Singh, Ram L ^b   Tekwani, Babu L ^c  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

^b DR RAM MANOHAR LOHIA AVADH UNIVERSITY   (India)

^c CENTRAL DRUG RESEARCH INSTITUTE   (India)

^d NONE   (India)

Author keywords

CML; Interferon alpha; ODC; Ornithine decarboxylase; Prognostic marker

Indexed keywords

ORNITHINE DECARBOXYLASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL PROLIFERATION; CHRONIC DISEASE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE MARKER; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; HUMAN; HUMAN CELL; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TUMOR GROWTH;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; LEUKEMIA, MYELOID, CHRONIC; LEUKOCYTES; MALE; MIDDLE AGED; ORNITHINE DECARBOXYLASE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 0036171721     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(01)00142-4     Document Type: Article

References (41)

1. A minute chromosome in human chronic granulocytic leukemia
2. Fused transcript of abl and bcr genes in chronic myelogenous leukemia
3. A multivariate analysis of prognostic factors in chronic myeloid leukemia
4. Prognostic features at diagnosis of chronic myelocytic leukemia
5. Polyamines
6. Recent advances in the biochemistry of the polyamines in eukaryotes
7. Regulation of ornithine decarboxylase gene expression in mouse epidermis and epidermal tumors during two stage tumorigenesis
8. Increased ornithine decarboxylase activity in murine sarcoma virus infected cells
9. The mechanism of ornithine decarboxylase deregulation in c-Ha-ras oncogene transformed NIH3T3 cells
10. Ornithine decarboxylase activity is critical for cell transformation
11. Polyamines diamines oxidase, and ornithine decarboxylase activity in colorectal cancer and in normal surrounding mucosa
12. Prognostic value of ornithine decarboxylase and polyamines in human breast cancer: Correlation with clinico-pathologic parameters
13. Elevated expression of the ornithine decarboxylase gene in human esophegal cancer
14. Over expression of ornithine decarboxylase in prostrate cancer and prostatic fluid in humans
15. Polyamines level and ornithine decarboxylase activity in intestinal-type and diffused-type gastric carcinoma
16. Ornithine decarboxylase and polyamine in familial adenomatous polyposis
17. Ornithine decarboxylase a predictor for tumor chemosensitivity
18. Staging of chronic myeloid leukemia
19. Ornithine decarboxylase
20. Hematologic remission and cytogenetic improvement induced by the recombinant human interferon alpha in chronic myeloid leukemia
21. Prognostic discrimination in good risk chronic granulocytic leukemia
22. Methylation of c-abl promoter: A prognostic factor in chronic meylogenous leukemia
23. p53 mutation indicates a changing clonal evolution in patients of chronic myelocytic leukemia patients
24. Allotype analysis in the evolution of the chronic myelocytic leukemia
25. A novel quantitative stretch PCR assay, that detects a dramatic increase in telomerase activity during the progression of myeloid leukemias
26. Ornithine decarboxylase
27. Evaluation of polyamines, S-phase fraction and anueploidy in chronic myeloid leukemia
28. Involvement of protein kinase activation in ornithine decarboxylase gene expression in primary culture of new born mouse epidermal cells and in skin tumor promotion by 12-o-tetra-ade-ecanocyl phorphol-13-acetate
29. Translational regulation of ornithine decarboxylase by polyamines
30. The induction of ornithine decarboxylase activity and its control in mouse skin epidermis
31. Chronic myeloid leukemia
32. Colonic polyamine content and ornithine decarboxylase as marker for adenomas
33. Effect of over expression of ornithine decarboxylase on growth control and oncogene induced cell transformation
34. Chronic myeloid leukemia - Recent advances
35. Multidrug resistance protein expression in chronic myeloid leukemia: Associations and significance
36. Differential effect of interferon on DNA synthesis, 2-deoxyglucose uptake and ornithine decarboxylase activity in 3T3 cells stimulated by polypeptide growth factors and tumor promoters
37. Difluromethylornithine and leukocytes interferon: A phase I clinical study in cancers patients
38. Additive and differential activity of alpha-interferon A, difluromethylornithine and their combination on established human lung cancer cell line
39. Development of difluoromethylornithine as a chemopreventive agent
40. Treatment of recurrent gliomas with BCNU and DFMO
41. Treatment of acute myeloid leukemia and blast phase of chronic myeloid leukemia with combination of eflrnithine (DFMO) and methyl glyoxal-bis-guanyl hydrazone (methyl-GAG)